Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: Triffin who wrote (5715)	7/14/2020 10:51:09 PM
From: Investor2	1 Recommendation Recommended By Savant Read Replies (1) \| Respond to of 22882

Yes, I heard about that study earlier today. The irvermectin cocktail (100% recovery rate) and the HCQ cocktail (96.36% recovery rate) were both very effective treatments as compared to the control group. Another study came out today that concluded that adding irvermectin to a HCQ/ARZ cocktail improved the treatment effectiveness. It should be noted that both studies came out as pre-prints; they have not yet been peer reviewed. Nevertheless, this is great news! We need cures! Especially with the reports coming out that the antibodies may not last very long, which calls into question the viability of vaccines. Best wishes, I2